AeroLeads people directory · profile
Philip Johnson Email & Phone Number
Senior Vice President, Oncology Development at Lilly
at
Ipsen
1 work email found
@loxooncology.com
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Senior Vice President, Oncology Development at Lilly
Location
New York City Metropolitan Area, United States, United States
Who is Philip Johnson? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Philip Johnson is listed as Senior Vice President, Oncology Development at Lilly at Ipsen, based in New York City Metropolitan Area, United States, United States. AeroLeads shows a work email signal at loxooncology.com and a matched LinkedIn profile for Philip Johnson.
Philip Johnson previously worked as Senior Vice President, Oncology Development at Eli Lilly And Company and Vice President / Head of Regulatory Affairs & Medical Writing at Loxo@Lilly. Philip Johnson holds Master Of Business Administration - Mba, Management Of Science And Innovation from Rutgers Business School.
Company email context
Email format at Ipsen
This section adds company-level context without repeating Philip Johnson's masked contact details.
{first_initial}{last}@loxooncology.com
86% confidence
AeroLeads found 1 current-domain work email signal for Philip Johnson. Compare company email patterns before reaching out.
Profile bio
About Philip Johnson
I have a total of 28 years of pharmaceutical drug development experience across a range of therapeutic areas and products. I am currently the Senior Vice President of Oncology Development for Lilly, where I lead the Project Leadership & Management, Clinical Operations, Biostatistics, Data Management, Regulatory Affairs, Medical Writing, and Business Operation functions supporting oncology programs from through clinical development. I was previously the Vice President & Head of Regulatory Affairs & Medical Writing for Loxo@Lilly.Prior to joining Lilly, I was a Medicine Team Leader at Pfizer, where I led cross-functional medicine teams for Besponsa (inotuzumab ozogamicin) and Daurismo (glasdegib) to successful regulatory approvals in the US, Europe and the Rest-of-World. Prior to Pfizer, I was a Senior Director of Regulatory Affairs at Bayer, where I led a team of 6 US and European-based regulatory professionals focused on the global regulatory strategy for a portfolio of Bayer's oncology drugs. The global oncology portfolio under my management includes the marketed drugs Aliqopa, Nexavar and Stivarga, as well as compounds currently in development. I have led multiple regulatory filings for these compounds, obtaining priority review approval for each of these filings.Specialties: Oncology, Hematology, Cross-Functional Leadership, Regulatory Affairs, FDA, NDA, BLA, IND, Advisory Committees, Diagnostic Imaging, Diabetes/Metabolism, Rheumatology/Autoimmune, Virology, Anti-Infectives
Listed skills include Regulatory Affairs, Fda, Oncology, Ind, and 3 others.
Current workplace
Philip Johnson's current company
Company context helps verify the profile and gives searchers a useful next step.
16 roles
Philip Johnson work experience
A career timeline built from the work history available for this profile.
Senior Vice President, Oncology Development
CurrentI lead the Early Oncology Development organization for Lilly, inclusive of Project Leadership & Management, Clinical Operations, Biostatistics, Data Management, Regulatory Affairs, Medical Writing, and Business Operations functions, with responsibilities spanning from IND filings through NDA/BLA approvals and lifecycle development.
May 2023 - Present
Vice President / Head Of Regulatory Affairs & Medical Writing
I led a team of 20 Regulatory and Medical Writing professionals supporting all Loxo@Lilly oncology programs from discovery through NDA/BLA approval. Key Regulatory responsibilities included IND filings and coordination of rest-of-world CTA filings, development and alignment of regulatory strategies with internal stakeholders and external regulators to.
Nov 2020 - May 2023
Medicine Team Leader - Oncology
At Pfizer, I led the Medicine Team in the submission & approval of Daurismo (glasdegib) by FDA & EMA for acute myeloid leukemia, as well the approval of Besponsa (inotuzumab ozogamicin) by FDA & EMA for acute lymphoblastic leukemia, in addition to multiple life-cycle development programs for those medicines. I have also led an immuno-oncology program in.
May 2017 - Oct 2020
Senior Director, Group Head, Oncology, Global Regulatory Affairs
Responsible for managing a team of 6 US & European-based regulatory professionals focused on the global regulatory strategy for a portfolio of Bayer's oncology drugs. The global oncology porfolio I managed included the marketed drugs Aliqopa (copanlisib), Stivarga (regorafenib), and Nexavar (sorafenib), as well as multiple oncology compounds currently in.
Jun 2016 - Apr 2017
Director, Global Head, Oncology, Global Regulatory Affairs
Responsible for managing a team of 6 US & European-based regulatory professionals focused on the global regulatory strategy for a portfolio of Bayer's oncology drugs. The global oncology porfolio I managed included the marketed drugs Nexavar and Stivarga, the Pi3K inhibitor Copanlisib, as well as multiple oncology compounds currently in early development.I.
Mar 2013 - Jun 2016
Interim Head, Asia Pacific, Global Regulatory Affairs
Managed team of 55 regulatory professionals including direct line management of 12 Asia-Pacific Country Heads plus 3 Regional Regulatory Strategists. Responsible for Bayer’s development and market portfolio in Asia-Pacific to obtain health authority approvals with competitive labeling while maintaining optimal regulatory compliance.Ensured alignment of.
Aug 2014 - Jan 2015
Deputy Director, Regulatory Affairs - Oncology, Diagnostic Imaging
Led multidisciplinary team in preparing and filing multiple New Molecular Entity NDAs, obtaining 1st cycle NDA approvals. Led all interactions between Bayer and FDA, including labeling negotiations and responses to clinical and pre-clinical questions. Led meetings with FDA for lifecycle development opportunities.Led 30-member team and coordinated with 3.
Oct 2009 - Feb 2013
Associate Director, Regulatory Affairs
Jun 2008 - Oct 2009
Senior Program Manager, Regulatory Affairs
Jun 2005 - May 2008
Program Manager, Regulatory Affairs
Sep 2003 - May 2005
Manager, Regulatory Affairs
Schering-Plough Healthcare Products
Dec 2001 - Sep 2003
Senior Regulatory Affairs Associate
Schering-Plough Healthcare Products
Jan 2000 - Nov 2001
Regulatory Affairs Supervisor
Pharmaceutical Formulations, Inc.
Jun 1998 - Dec 1999
Regulatory Affairs Associate
Pharmaceutical Formulations, Inc.
Jul 1997 - Jun 1998
Regulatory Affairs Assistant
Pharmaceutical Formulations, Inc.
May 1996 - Jul 1997
3 education records
Philip Johnson education
Master Of Business Administration - Mba, Management Of Science And Innovation
Rutgers Business School
Raps Executive Development Program, Regulatory Management
Northwestern University - Kellogg School Of Management
Bachelor Of Science - Bs, Chemistry
Brown University
FAQ
Frequently asked questions about Philip Johnson
Quick answers generated from the profile data available on this page.
What company does Philip Johnson work for?
Philip Johnson works for Ipsen.
What is Philip Johnson's role at Ipsen?
Philip Johnson is listed as Senior Vice President, Oncology Development at Lilly at Ipsen.
What is Philip Johnson's email address?
AeroLeads has found 1 work email signal at @loxooncology.com for Philip Johnson at Ipsen.
Where is Philip Johnson based?
Philip Johnson is based in New York City Metropolitan Area, United States, United States while working with Ipsen.
What companies has Philip Johnson worked for?
Philip Johnson has worked for Ipsen, Eli Lilly And Company, Loxo@Lilly, Pfizer, and Bayer Pharmaceuticals.
How can I contact Philip Johnson?
You can use AeroLeads to view verified contact signals for Philip Johnson at Ipsen, including work email, phone, and LinkedIn data when available.
What schools did Philip Johnson attend?
Philip Johnson holds Master Of Business Administration - Mba, Management Of Science And Innovation from Rutgers Business School.
What skills is Philip Johnson known for?
Philip Johnson is listed with skills including Regulatory Affairs, Fda, Oncology, Ind, Medical Imaging, Regulatory Strategy, and Pharmaceuticals.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial